Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
  1. 4 Shares withheld for taxes President and CEO gave up 2,734 shares (to pay taxes)
  2. 4 Open-market buy Director bought 20,000 shares at $2.48 ($49,680)
  3. 4 Open-market buy Chief Legal Officer and GC bought 10,000 shares at $2.50 ($25,000)
  4. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,720 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 354 shares (to pay taxes)
  7. 4 Shares withheld for taxes President and CEO gave up 10,685 shares (to pay taxes)
  8. 4 Grant or award President and CEO acquired 34,705 shares (grant or award)
  9. 4 Shares withheld for taxes CFO gave up 353 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,719 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CEO gave up 10,683 shares (to pay taxes)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes CFO gave up 354 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Scientific Officer gave up 1,719 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Legal Officer and GC gave up 1,813 shares (to pay taxes)

Page 7 of 17 · 330 filings